News & Updates
Laboratory Reporting Negative HIV and HEP C Tests
Summary On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to the Nevada Administrative Code (NAC) 441A that updated reporting requirements for both hepatitis C virus (HCV) and human...
Updates to NAC 441A, Regarding Reportable Communicable Diseases in Nevada
Background On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to Nevada Administrative Code (NAC) 441A that updated the conditions which are mandated to be reported in Nevada. These...
CDC Provides New Laboratory Recommendations for Syphilis Testing
Introduction Currently, no available nucleic acid amplification tests (NAATs) are cleared by Food and Drug Administration (FDA) for marketing in the United States to screen or diagnose syphilis, and culture...
Candida auris regulation changes
Background Candida auris (C. auris) is a newly emerging biological fungal agent that can cause severe illnesses. It is known to be resistant to most antifungal treatments and can spread...
Concerning Tuberculosis Trends and Guidance to Identify and Eliminate Tuberculosis
Summary of Concerning Tuberculosis Trends in Nevada To eliminate TB, Nevada’s public health systems in collaboration with health care providers need to increase identification of individuals at risk for TB,...
National Shortage of Erythromycin 0.5% Ophthalmic Ointment (erythromycin)
Gonorrhea ocular prophylaxis of newborns is mandated by law and is considered standard neonatal care in Nevada. Nevada Revised Statute (NRS) 442.050 and NRS 442.060 require every “physician or midwife...
ARPA Nevada Health Workforce Pipeline Grant to the Public Health Infrastructure and Improvement
The American Rescue Plan Act (ARPA) Nevada Health Workforce Pipeline Grant (NHWPG) will focus on providing funding opportunities that are intended to disseminate financial relief and incentivize individuals to pursue...
FDA Approves Use of Respiratory Syncytial Virus (RSV) Immunization for Pregnant Individuals to Prevent RSV in Infants
Background On August 21, 2023, the U.S. Food and Drug Administration approved ABRYSVO (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory...
Hantavirus in Nevada
Summary To date in 2023 there have been four (4) cases of hantavirus reported in Nevada. One case was hantavirus infection, Non-Hantavirus Pulmonary Syndrome in Washoe County; and three (3)...
Updated Operational Guidance for Implementation of CDC’s Hepatitis C Infection Testing Recommendations
Background The Centers for Disease Control and Prevention (CDC) has updated the operational guidance for implementing the recommendations related to testing for hepatitis C virus (HCV) infection.1 Accurate and complete testing...
Use Limitations for Portable and Mobile X-ray Machines
This technical bulletin pertains to the medical use of portable and mobile radiation-producing machines in Nevada. Radiation-producing machines are regulated under Nevada Revised Statutes (NRS) Chapter 459 and Nevada Administrative...
FDA Approves Use of Respiratory Syncytial Virus Vaccines (RSV) for Adults 60 and Older
Background In May 2023, the U.S. Food and Drug Administration (FDA) approved two different vaccines (from GSK and Pfizer) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract...